Our Mission
The era of longevity medicine is approaching, and we aim to become a cornerstone of the Longevity Industry.
VitaSpring aims to build a cell medical industry, invest in research and development of stem cell applications in regenerative medicine, establish advanced medical research centers and high standard cell production centers, all while adhering to the FDA’s GTP (Good Tissue Practice) standard stem cell preparations for the development of cellular medicine. Through the development of stem cell medicine, it will become a leading international business group in the fields of regenerative medicine applied to medicine, preventive health care, cosmetics, and anti-aging.
The era of longevity medicine is approaching, and we aim to become a cornerstone of the Longevity Industry.
VitaSpring aims to build a cell medical industry, invest in research and development of stem cell applications in regenerative medicine, establish advanced medical research centers and high standard cell production centers, all while adhering to the FDA’s GTP (Good Tissue Practice) standard stem cell preparations for the development of cellular medicine. Through the development of stem cell medicine, it will become a leading international business group in the fields of regenerative medicine applied to medicine, preventive health care, cosmetics, and anti-aging.